Brookhaven IDA closes on incentives pact enabling biotech firm to purchase 10,000 s/f in Bellport

Bellport, NY Frederick Braun III, chairman of the town of Brookhaven Industrial Development Agency (IDA) said that the IDA has closed on a package of economic incentives that will allow a biotechnology company in Stony Brook University’s Long Island High Tech Incubator (LIHTI) to buy and equip an industrial building, allowing it to expand and return outsourced manufacturing to Long Island.

The closing on June 6, 2025, involves incentives for Biocogent LLC, which focuses on research, development, and the manufacturing of biologically active dermatologic ingredients for skincare. It manufactures 17 dermatologic products, including a bacteriophage to treat acne, which are sold to over-the-counter skincare and medical care markets, with $20 million in global sales.

The incentives will enable Biocogent to buy a 10,000 s/f building at 9 Sawgrass Dr. near two existing facilities used by the company. The total cost of the project is $4.25 million. It will allow the company, which has 42 employees with an average salary of $129,000, to create six more positions.

Biocogent, which has 12,000 s/f at the incubator, plans to discontinue using the university space, where it conducts research and development. It said space limitations have constrained its growth.

The new project will be the third building at the company’s campus. The first is used for operating and warehouse space, the second for process manufacturing, and the third for research and development, and bio-manufacturing.

Biocogent is buying the building, formerly used to distribute electronic components, from CJR Holding LLC.